L'Oreal reports that weight loss drugs are impacting beauty sales as the company develops new products to address skin changes.
Beauty company L'Oreal confirms that weight loss drugs are changing consumer habits. These medications, known as GLP-1s, currently influence the global beauty market.
Next, the company reports that these drugs affect skin care sales significantly. Leaders at L'Oreal view this trend as a very important shift for their business.
Also, the firm notes that rapid weight loss often causes loose skin. This issue frequently occurs around the face for many users.
Then, L'Oreal executives explained their strategy during a recent investor call. They now design specific products to address these physical changes.
Meanwhile, brands like SkinCeuticals and Kiehl's offer solutions for these side effects. These products help customers manage skin sagging caused by weight loss.
After that, the company shared positive financial news this week. L'Oreal saw sales grow by 7.7 percent during the third quarter.
Furthermore, the business continues to expand into the clinical aesthetic market. They increased their stake in the dermatology firm Galderma to 20 percent.
Still, both companies are testing new products for GLP-1 users. These trials focus on concerns about changes in facial appearance after losing weight.
Finally, Galderma reports that most drug users notice differences in their face. Their popular injectables help stimulate collagen to improve skin texture.